Logo

American Heart Association

  59
  0


Final ID: 020

Risk of Ventricular Arrhythmia Development due to Hypoglycemia in Diabetic Patients

Abstract Body: Introduction: Hypoglycemia, a known complication of diabetic medications, has been linked to increased cardiovascular risk. Ventricular arrhythmias, particularly ventricular tachycardia (VT) and ventricular fibrillation (VF), are major contributors to sudden cardiac death.
Hypothesis: This study evaluates the association between hypoglycemia and ventricular arrhythmias and related complications in hospitalized diabetic patients using the National Inpatient Sample (NIS) database.
Methods: A retrospective cohort study was conducted using the NIS database (2016–2019). Adult patients with diabetes (ICD-10-CM: E10, E11) and hypoglycemia (ICD-10-CM: E16.2, E10.649, E11.649, E16.A1–A3) were identified. Primary outcomes included incidence of VT and VF; secondary outcomes included atrial fibrillation, acute coronary syndrome (ACS), respiratory failure, and in-hospital mortality. Multivariable logistic regression adjusted for demographics, comorbidities, and disease severity.
Results: Of 6,465,478 hospitalized adults with diabetes, 0.05% (306,329) had hypoglycemia. Mean age was 65.7 ± 14.7 years; 50.5% were male, 63.3% Caucasian. In-hospital mortality among hypoglycemic patients was 4.28%. VT occurred more frequently in hypoglycemic vs. non-hypoglycemic patients (2.30% vs. 1.85%, p < 0.0001), as did VF (0.33% vs. 0.31%, p = 0.019) and atrial fibrillation (21.61% vs. 21.30%, p < 0.001). Hypoglycemia was independently associated with higher odds of VT (OR 1.08, 95% CI: 1.05–1.10, p < 0.0001), and also increased risk of in-hospital mortality, ACS, cardiac arrest, respiratory failure, and acute kidney injury.
Conclusions: In this large national cohort, hypoglycemia in diabetic patients was associated with increased risk of ventricular and atrial arrhythmias, mortality, and other complications. These findings suggest hypoglycemia may be an independent marker of cardiovascular vulnerability. Enhanced monitoring and glycemic control may reduce adverse outcomes in this high-risk population. Further studies are needed to explore causal mechanisms.
  • Ahmed, Sana  ( Northeast Georgia Medical Center , Gainesville , Georgia , United States )
  • Mahmood, Riaz  ( Northeast Georgia Medical Center , Gainesville , Georgia , United States )
  • Salih, Rayan  ( Northeast Georgie Medical Center , Flowery branch , Georgia , United States )
  • Patel, Sharvil  ( Northeast Georgia Medical Center , Gainesville , Georgia , United States )
  • Egolum, Ugochukwu  ( Georgia Heart Institute , Gainesville , Georgia , United States )
  • Author Disclosures:
    Sana Ahmed: DO NOT have relevant financial relationships | Riaz Mahmood: No Answer | Rayan Salih: DO NOT have relevant financial relationships | Sharvil Patel: No Answer | Ugochukwu Egolum: No Answer
Meeting Info:
Session Info:

Concurrent A: Unlocking the Cardiometabolic Code of Hypertension (TAC Session)

Thursday, 09/04/2025 , 03:30PM - 05:30PM

Oral Abstract Session

More abstracts on this topic:
Early GLP-1 Receptor Agonist Initiation Reduces Major Cardiac and Renal Events in Older Adults with Type 2 Diabetes Without Prior Cardiovascular or Renal Disease: A Target Trial Emulation

Chi Kuan Yu, Chang Yu, Varrias Dimitrios, Nanna Michael, Nouri Armin, Lee Pei-lun, Hsieh Rebecca, Mangalesh Sridhar, Hu Jiun-ruey, Ezenna Chidubem, Akman Zafer, Romero Acero Laura

Anaerobic glycolysis mediates hyperglycemia in cytoplasm during ischemia

Lee Seeun, Kim Nain, You Zerong, Kim Hyung-hwan, Zhong Wenliang, Lee Eun-hye, Jiao Qian, Jang Dongyeol, Cho Suin, Lim Chiyeon, Lim Sehyun, Elsayed Mahmoud

You have to be authorized to contact abstract author. Please, Login
Not Available